. Author manuscript; available in PMC: 2015 Dec 4.

Published in final edited form as: Target Oncol. 2015 Jan 6;10(4):501–508. doi: 10.1007/s11523-014-0353-6

Table 1.

Afatinib IC₅₀s compared to gefitinib IC₅₀s of SCCHN cell lines

Cell line	Afatinib IC₅₀ (μM)	Confidence interval	Gefitinib IC₅₀ (μM)
SCC25	0.0102	9.796e-005to 1.062	5-10
HN5	0.06412	0.009348 to 0.4398	0.05-0.5
SCC58	0.3405	0.07144 to 1.623	>100
SQ20B	0.5176	0.08746 to 3.064	1-5
MSK921	1.174	0.6654 to 2.071	1-5
HN31	1 225	0.8320 to 1.805	1 -5
SCC61	1.903	0.6092 to 5.942	5
SCC28	1.951	0.7886 to 4.827	>5
Detroit 562	2.485	0.9399 to 6.569	5-50
SCC35	8.008	5.645 to 11.36	100